Indications for "Fiziotenza" and its analogues



Medicament "Fiziotenz" made in Germany pharmaceutical company Solvay Pharmaceuticals BVIts analogue "Moksoniteks" is produced by the German company Salutas Pharma.Its analogue "Cynthia" is manufactured by «Eli Lilly» (USA)."Moxonidine" produces the Russian "Farmzaschita."These drugs are prescribed for the treatment of hypertension.All drugs have the same active ingredient - moxonidine.

Moxonidine stimulates the sensory receptors involved in the management of the sympathetic nervous system, activation of these receptors lowers blood pressure."Fiziotenz" or its analogues administered at a dose of 200 micrograms per day, the maximum amount of product per day is 600 mg, the maximum possible single dose - 400 micrograms.Take "Fiziotenz" or its analogues can be replaced
only after consultation with a physician, self can be dangerous. If the patient suffers from renal failure daily dose should be 200 mg.

Side effects, contraindications to preparations containing moxonidine



«Fiziotenz" and analogues of guests can cause the same side effects: temporary dysfunction of the central nervous system (headache, dizziness, drowsiness), excessive pressure drop, tongue and mouth become dry.These drugs should not be taken during pregnancy and lactation.During treatment it is necessary to eliminate the use of alcohol at the beginning of therapy is not recommended to work with mechanisms that require quick response and attention.

«Fiziotenz" and analogues are contraindicated at the age of 18, in case of hypersensitivity to the active component of the drug, with hereditary galactose intolerance, sick sinus syndrome, bradycardia (low frequency of heart beats).Due to the lack of clinical experience the use of preparations containing moxonidine in patients with intermittent claudication, Raynaud's disease, depression, epilepsy, Parkinson's, glaucoma can be dangerous. «Fiziotenz" and analogues with extreme caution should be taken in patients with renal insufficiency and patients on hemodialysis.

If medicines containing moxonidine administered together with the drugs - beta-blockers, the effect of moxonidine on blood pressure increases.After the abolition of "Fiziotenza" and unique due to the ongoing treatment of beta-blockers have a risk of severe arterial hypertension.So in this case it is recommended to cancel the beta-blocker, and a few days later with the drug Moxonidine.With the simultaneous use of these funds with the drugs have a depressing effect on the central nervous system (sleeping pills, tranquilizers), deprimiruyuschee (overwhelming) influence on the central nervous system is enhanced.